nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia
|
Chandran, Manju |
|
|
33 |
1 |
p. 251-261 |
artikel |
2 |
A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis
|
Varenna, M. |
|
|
33 |
1 |
p. 299-303 |
artikel |
3 |
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study
|
Adami, G. |
|
|
33 |
1 |
p. 169-176 |
artikel |
4 |
A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis
|
Singh, S. |
|
|
33 |
1 |
p. 1-12 |
artikel |
5 |
Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis
|
Zhang, Y. |
|
|
33 |
1 |
p. 27-37 |
artikel |
6 |
Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
|
Böcker, W. |
|
|
33 |
1 |
p. 87 |
artikel |
7 |
Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis
|
Nayak, S. |
|
|
33 |
1 |
p. 229-238 |
artikel |
8 |
Craniocervical abnormalities in osteogenesis imperfecta type V
|
Ludwig, K. |
|
|
33 |
1 |
p. 177-183 |
artikel |
9 |
Cultivating across “pockets of excellence”: challenges to sustaining efforts to improve osteoporosis care
|
Seaman, Aaron T. |
|
|
33 |
1 |
p. 139-147 |
artikel |
10 |
Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report
|
Park, S.Y. |
|
|
33 |
1 |
p. 305-308 |
artikel |
11 |
Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review
|
Beaudart, Charlotte |
|
|
33 |
1 |
p. 13-26 |
artikel |
12 |
Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
|
Deminger, A. |
|
|
33 |
1 |
p. 205-216 |
artikel |
13 |
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
|
Thomasius, Friederike |
|
|
33 |
1 |
p. 217-228 |
artikel |
14 |
Fractures and fall injuries after hospitalization for seasonal influenza—a national retrospective cohort study
|
Axelsson, K. F. |
|
|
33 |
1 |
p. 47-56 |
artikel |
15 |
Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis
|
Böcker, Wolfgang |
|
|
33 |
1 |
p. 77-86 |
artikel |
16 |
FRAX-based intervention thresholds for Pakistan
|
Johansson, H. |
|
|
33 |
1 |
p. 105-112 |
artikel |
17 |
Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients
|
Schemitsch, Emil |
|
|
33 |
1 |
p. 113-122 |
artikel |
18 |
In memoriam: Bernardo Stolnicki
|
Zerbini, C. |
|
|
33 |
1 |
p. 313 |
artikel |
19 |
Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis
|
Boschitsch, Ewald |
|
|
33 |
1 |
p. 263-272 |
artikel |
20 |
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study
|
Atmaca, A. |
|
|
33 |
1 |
p. 273-282 |
artikel |
21 |
Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy
|
Borges, Juliano Henrique |
|
|
33 |
1 |
p. 283-291 |
artikel |
22 |
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
|
Khalid, Sara |
|
|
33 |
1 |
p. 123-137 |
artikel |
23 |
One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD
|
Larsson, B.A.M. |
|
|
33 |
1 |
p. 185-194 |
artikel |
24 |
Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM)
|
Möller, Sören |
|
|
33 |
1 |
p. 57-66 |
artikel |
25 |
Primary hyperphosphatemic tumoral calcinosis: a case report
|
Huang, J. |
|
|
33 |
1 |
p. 309-312 |
artikel |
26 |
Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China
|
Hou, X.-l. |
|
|
33 |
1 |
p. 89-96 |
artikel |
27 |
Self-rated health status and activities of daily living in the first 12 months after fragility fractures of the pelvis—a prospective study on 134 patients
|
Hack, Juliana |
|
|
33 |
1 |
p. 161-168 |
artikel |
28 |
Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS)
|
Talevski, J. |
|
|
33 |
1 |
p. 67-75 |
artikel |
29 |
Teriparatide and pelvic fracture healing: a phase 2 randomized controlled trial
|
Nieves, J.W. |
|
|
33 |
1 |
p. 239-250 |
artikel |
30 |
Thirty years of hip fracture incidence in Austria: is the worst over?
|
Dimai, Hans Peter |
|
|
33 |
1 |
p. 97-104 |
artikel |
31 |
Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort
|
Vendrami, C. |
|
|
33 |
1 |
p. 195-204 |
artikel |
32 |
Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study
|
Leslie, W. D. |
|
|
33 |
1 |
p. 39-46 |
artikel |
33 |
Trends in fractures in patients with spondyloarthritis: a nationwide population-based study (TREND-EspA study)
|
Mazzucchelli, Ramon |
|
|
33 |
1 |
p. 149-159 |
artikel |
34 |
Zoledronic acid and bone health in older adults with cognitive impairment
|
Churilla, B.M. |
|
|
33 |
1 |
p. 293-298 |
artikel |